97 related articles for article (PubMed ID: 26990916)
1. FRY site-specific methylation differentiates pancreatic ductal adenocarcinoma from other adenocarcinomas.
Srisuttee R; Ota J; Muangsub T; Keelawat S; Trirattanachat S; Kitkumthorn N; Mutirangura A
APMIS; 2016 Jun; 124(6):469-74. PubMed ID: 26990916
[TBL] [Abstract][Full Text] [Related]
2. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
3. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis.
Mardin WA; Ntalos D; Mees ST; Spieker T; Senninger N; Haier J; Dhayat SA
Pancreas; 2016; 45(5):743-7. PubMed ID: 26646275
[TBL] [Abstract][Full Text] [Related]
4. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Ductal Adenocarcinoma.
Dhillon J; Betancourt M
Monogr Clin Cytol; 2020; 26():74-91. PubMed ID: 32987385
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
7. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pancreatic Cancer in Biliary Obstruction Patients by FRY Site-specific Methylation.
Angsuwatcharakon P; Rerknimitr R; Kongkam P; Ridtitid W; Ponauthai Y; Srisuttee R; Kitkumthorn N; Mutirangura A
Asian Pac J Cancer Prev; 2016; 17(9):4487-4490. PubMed ID: 27797266
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
11. Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.
Franklin O; Öhlund D; Lundin C; Öman M; Naredi P; Wang W; Sund M
Cancer Biomark; 2015; 15(1):1-10. PubMed ID: 25524936
[TBL] [Abstract][Full Text] [Related]
12. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Ductal Adenocarcinoma and Its Variants.
Luchini C; Capelli P; Scarpa A
Surg Pathol Clin; 2016 Dec; 9(4):547-560. PubMed ID: 27926359
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MSX2 mRNA in brush cytology specimens distinguished pancreatic carcinoma from chronic pancreatitis.
Satoh K; Hamada S; Kanno A; Ishida K; Ito H; Hirota M; Masamune A; Egawa S; Unno M; Shimosegawa T
Cancer Sci; 2011 Jan; 102(1):157-61. PubMed ID: 20961362
[TBL] [Abstract][Full Text] [Related]
15. Imaging for pancreatic ductal adenocarcinoma.
Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
[TBL] [Abstract][Full Text] [Related]
16. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma.
Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y
Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503
[TBL] [Abstract][Full Text] [Related]
17. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
[TBL] [Abstract][Full Text] [Related]
18. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
[TBL] [Abstract][Full Text] [Related]
20. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma.
Deshpande V; Lauwers GY
Cancer; 2007 Feb; 111(1):47-53. PubMed ID: 17173321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
